Wu, Y.-L., Lee, V., Liam, C.-K., et al. (2018) Clinical Utility of a Blood-Based EGFR Mutation Test in Patients Receiving First-Line Erlotinib Therapy in the ENSURE, FASTACT-2, and ASPIRATION Studies. Lung Cancer, 126, 1-8. - References

Journals by Subject

Publish with us

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Article citationsMore>>

Wu, Y.-L., Lee, V., Liam, C.-K., et al. (2018) Clinical Utility of a Blood-Based EGFR Mutation Test in Patients Receiving First-Line Erlotinib Therapy in the ENSURE, FASTACT-2, and ASPIRATION Studies. Lung Cancer, 126, 1-8.
https://doi.org/10.1016/j.lungcan.2018.10.004

has been cited by the following article:

Open Access

Articles

Final Results of a Phase II Study of Bevacizumab, Cisplatin and Pemetrexed as First-Line Therapy for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer

Guillermo López Vivanco, Eider Azkona, Sergio Carrera, Aintzane Sancho, Itziar Rubio, Juan Manuel Mañé, Begoña Calvo, Unai Aresti, Aitziber Buque, Inés Marrodán, Alberto Muñoz

Journal of Cancer Therapy Vol.7 No.7, June 27, 2016

DOI: 10.4236/jct.2016.77047
Open Access

Articles

Clinical Predictors of Cetuximab for First-Line Therapy of Metastatic Colorectal Cancer: A Single Institutional Retrospective Study

Yuki Morishita, Hiroaki Tanioka, Motoi Asano, Kotomi Tokuyama, Hiroko Okamoto, Tomohisa Okamoto, Takako Oda, Masatoshi Ohta, Masayuki Fukuzawa

Journal of Cancer Therapy Vol.8 No.9, September 12, 2017

DOI: 10.4236/jct.2017.89072
Open Access

Articles

Cyclophosphamide, Thalidomide and Dexamethasone (CTD) as First-Line Therapy in Multiple Myeloma Patients: An Experience in a Clinical Haematology Centre in Dakar, Senegal

El Hadji Daouda Niang, Seynabou Fall, Khadim Sarr, Marième Lolita Camara, Aminata Dakono, Awa Ndiaye, Modou Moustapha Ciss, Amy Thiam, Serge Mwamba, Fatou Samba Diago Ndiaye

Open Journal of Blood Diseases Vol.13 No.1, March 10, 2023

DOI: 10.4236/ojbd.2023.131006
Open Access

Articles

Practical Use of Gemcitabine and Cisplatin Combination Therapy as First-Line Treatment for Japanese Patients with Advanced Biliary Tract Cancer

Hisato Kawakami, Isamu Okamoto, Wataru Okamoto, Masayuki Takeda, Shinya Ueda, Toshihiro Kudo, Shin-ichi Nishina, Yasuhito Fujisaka, Masaki Miyazaki, Junji Tsurutani, Takayasu Kurata, Kazuhiko Nakagawa

Journal of Cancer Therapy Vol.4 No.6, July 17, 2013

DOI: 10.4236/jct.2013.46121
Open Access

Articles

Phase II Study of Carboplatin and Pemetrexed Followed by Gefitinib for Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive EGFR Mutation

Saki Manabe, Fumihiro Oshita, Shuji Murakami, Tetsuro Kondo, Haruhiro Saito, Takeshi Kaneko, Kouzo Yamada

Journal of Cancer Therapy Vol.6 No.15, December 14, 2015

DOI: 10.4236/jct.2015.615132

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Free SCIRP Newsletters

Add your e-mail address to receive free newsletters from SCIRP.

Top

Journals by Subject

Publish with us

Article citationsMore>>

Home

About SCIRP

Service

Policies